Concepedia
Statistics
Publications
29
Citations
1.3K
H-Index
20
Active since
1984
Affiliations
Eli Lilly (United States)(Current)
Pharmaceutical Product Development (United States)
Worldwide Clinical Trials (United States)
MPI Research (United States)
Celerion (United States)
Alan P. Breau is an author at Eli Lilly (United States) specializing in pharmacology, pharmacy, and drug disposition.
Publications per year
1984–2012
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
John C. Lindon, Jeremy K. Nicholson, Elaine Holmes et al. · Toxicology and Applied Pharmacology · 2003 · 386 citations · Full text
Pharmacy, Toxicology, Biochemical Toxicology +13
Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats
Susan K. Paulson, Ji Y. Zhang, Alan P. Breau et al. · Drug Metabolism and Disposition · 2000 · 131 citations
Pharmacy, Pharmacokinetics, Pharmacology +12
Recommendations On: Internal Standard Criteria, Stability, Incurred Sample Reanalysis and Recent 483s by the Global CRO Council for Bioanalysis
Steve Lowes, Jim Jersey, Ronald E. Shoup et al. · Bioanalysis · 2011 · 88 citations
Pharmacy, Toxicology, Analytical Chemistry +13
Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human
Susan K. Paulson, Todd A. Kaprak, Christopher J. Gresk et al. · Biopharmaceutics & Drug Disposition · 1999 · 66 citations
Medicine, Pharmacokinetics, Pharmacology +8
Recommendations on The Interpretation of The New European Medicines Agency Guideline on Bioanalytical Method Validation By Global Cro Council For Bioanalysis (Gcc)
Mark Boterman, Mira Doig, Massimo Breda et al. · Bioanalysis · 2012 · 44 citations
Pharmacy, Pharmaceutical Analysis, Analytical Chemistry +15
1–5 of 29